...
首页> 外文期刊>Environmental toxicology and pharmacology >MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression
【24h】

MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression

机译:MicroRNA-375通过触发凋亡和调节PDK1表达来抑制肾癌细胞的增殖,迁移和侵袭

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Kidney cancer is one of the deadly cancers and is the cause of significant number of deaths worldwide. The treatments used for the treatment of kidney cancer are limited and associated with number of side effects. Therefore, there is need for the development of new drug options or to identify novel therapeutic targets for the treatment of kidney cancer. In this study we investigated the potential of miR-375 as the therapeutic target for the treatment of Kidney cancer. The results revealed that miR-375 is significantly downregulated in the Kidney cancer cells. To investigate the role therapeutic potential of miR-375, one kidney cancer cell line (A-498) was selected for further experimentation. It was observed that overexpression of miR-375 inhibits A-498 kidney cancer proliferation by induction of apoptosis. In addition, overexpression of miR-375 causes suppression of migration and invasion of the A-498 kidney cancers cells. Bioinformatic analysis revealed PDK1 to be putative target of miR-375 in Kidney cancer cells. The western blot analysis revealed the expression of PDK1 to be significantly upregulated in Kidney cancer cells and overexpression of miR-375 in A-498 cells caused inhibition of PDK1 preventing the phosphorylation of AKT (Thr(308) and Ser(473)). Additionally, inhibition of PDK1 had similar effects as that of miR-375 overexpression on cell proliferation of A-498 kidney cancer cells. The inhibition of miR-375 expression could not rescue the effects of PDK-1 suppression on A-498 cell proliferation. In contrary, overexpression of PKD1 in A-498 cells transfected with miR-375 mimics could nullify the effects of miR-375 on proliferation of the A-498 cells. Taken together, we conclude that miR-375 regulates cell proliferation, migration and invasion of A-498 kidney cancer cells and may prove to be an important therapeutic target.
机译:肾癌是致命的癌症之一,并且是全世界大量死亡的原因。用于治疗肾癌的疗法是有限的并且与副作用数量有关。因此,需要开发新的药物选择或鉴定用于治疗肾癌的新的治疗靶标。在这项研究中,我们调查了miR-375作为治疗肾癌的治疗靶标的潜力。结果表明,miR-375在肾脏癌细胞中显着下调。为了研究miR-375的治疗潜力,选择了一种肾癌细胞系(A-498)进行进一步的实验。观察到miR-375的过表达通过诱导凋亡来抑制A-498肾癌的增殖。此外,miR-375的过度表达会抑制A-498肾癌细胞的迁移和侵袭。生物信息学分析表明,PDK1是肾脏癌细胞中miR-375的假定靶标。蛋白质印迹分析表明,PDK1的表达在肾脏癌细胞中显着上调,而miR-375在A-498细胞中的过表达引起PDK1的抑制,从而阻止了AKT的磷酸化(Thr(308)和Ser(473))。另外,PDK1的抑制与miR-375过表达对A-498肾癌细胞的细胞增殖具有相似的作用。对miR-375表达的抑制不能挽救PDK-1抑制对A-498细胞增殖的影响。相反,在用miR-375模拟物转染的A-498细胞中PKD1的过表达可能会使miR-375对A-498细胞增殖的作用无效。两者合计,我们得出结论,miR-375调节A-498肾癌细胞的细胞增殖,迁移和侵袭,可能被证明是重要的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号